All lobbying filings

THE MCMANUS GROUP

Lobbying for INFUSION PROVIDERS ALLIANCE · Association representing infusion drug providers.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $90,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Health Issues

Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging. Issues related to patient access to products for asthma and allergies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.